Page 3 - 18F-FDG PET as biomarker in aggressive lymphoma; technical and clinical validation
P. 3

                                18F-FDG PET as biomarker in aggressive lymphoma; technical and clinical validation
Coreline Burggraaff 2022
   1   2   3   4   5